Coherus Announces FDA Approval of Udenyca Onbody ™, a Novel and Proprietary State-of-the-Art Delivery System for pegfilgrastim-cbqv

Innovative design enables five-minute pegfilgrastim delivery time Unique, automatic, retractable needle mechanism engineered to maximize safety and comfort for cancer patients receiving pegfilgrastim REDWOOD CITY, Calif., Dec. 26, 2023 (GLOBE...
Source: Drugs.com - New Drug Approvals - Category: Drugs & Pharmacology Source Type: news